Common Contracts
3 similar Employment Agreement contracts by Biocryst Pharmaceuticals Inc
August 4, 2021 Mrs. Alane Barnes abarnes@biocryst.com Dear Ms. Barnes:Employment Agreement • August 9th, 2021 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
As part of our review of the terms of our employment agreements with our executives and our intentions to align the terms of such agreements so that they are generally consistent with one another, this letter agreement (the “Agreement”) amends and restates the employment letter agreement, dated August 2, 2013, as amended November 18, 2013, previously entered into between you and us. You are currently employed by BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), as Chief Legal Officer, reporting directly to the President and Chief Executive Officer. This Agreement will serve to confirm our agreement with respect to the terms and conditions of your continued employment.
August 4, 2021 Dr. William Sheridan bsheridan@biocryst.com Dear Dr. Sheridan:Employment Agreement • August 9th, 2021 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
As part of our review of the terms of our employment agreements with our executives and our intentions to align the terms of such agreements so that they are generally consistent with one another, this letter agreement (the “Agreement”) amends and restates the employment letter agreement, dated June 12, 2008, as amended November 18, 2013, previously entered into between you and us. You are currently employed by BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), as Chief Medical Officer, reporting directly to the Chief Research & Development Officer. This Agreement will serve to confirm our agreement with respect to the terms and conditions of your continued employment.
August 4, 2021 Dr. Y.S. Babu babu@biocryst.com Dear Dr. Babu:Employment Agreement • August 9th, 2021 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Alabama
As part of our review of the terms of our employment agreements with our executives and our intentions to align the terms of such agreements so that they are generally consistent with one another, this letter agreement (the “Agreement”) amends and restates the employment letter agreement, dated April 27, 2012, as amended November 18, 2013, previously entered into between you and us. You are currently employed by BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), as Chief Discovery Officer, reporting directly to the Chief Research & Development Officer. This Agreement will serve to confirm our agreement with respect to the terms and conditions of your continued employment.
